Vera Therapeutics VERA Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Vera Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vera Therapeutics's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vera Therapeutics's interest coverage?
- Vera Therapeutics (VERA) reported interest coverage of -50.7× in Q1 2026.
- How has Vera Therapeutics's interest coverage changed year-over-year?
- Vera Therapeutics's interest coverage decreased by 97.1% year-over-year, from -25.7× to -50.7×.
- What is the long-term trend for Vera Therapeutics's interest coverage?
- Over 5 years (2020 to 2025), Vera Therapeutics's interest coverage has grown at a -33.2% compound annual growth rate (CAGR), from -314.7× to -41.9×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.